Information and communication in the context of a clinical trial

被引:60
作者
Hietanen, P
Aro, AR
Holli, K
Absetz, P
机构
[1] Univ Helsinki Hosp, Dept Oncol, FIN-00029 Helsinki, Finland
[2] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00029 Helsinki, Finland
[3] Tampere Univ Hosp, Dept Oncol, Tampere, Finland
关键词
information; communication; clinical trial; randomisation; sociodemographics;
D O I
10.1016/S0959-8049(00)00191-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to determine the communicative needs of the patients in the context of being invited to participate in a clinical trial. A questionnaire was sent to 299 patients with breast cancer randomised in a trial of adjuvant therapy. It was returned by 361 (87%) of them. Ninety-one per cent (231/255) of the patients regarded the information provided as easy or quite easy to understand. However. the method of treatment allocation was unclear to most patients: 51% (128/251) thought that the doctor had chosen the treatment while only 23% (57/251) knew that they had been randomised. Younger and better educated patients had a better understanding. For 55% (125/226) of the patients written information had been helpful in decision making. This correlated highly with the education of the patient. Sixty-eight per cent (174/255) of the patients thought that they had enough time for decision-making. Less educated patients and older patients had needed more time. Eighty-seven per cent (218/251) were happy with their decision to participate. While most patients are satisfied with the information received, there is a poor understanding of how treatment is allocated. Information should be modified for older and less-educated patients. The needs of the patients when offered participation in a clinical trial are clear information, enough time to consider the options and psychological support. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2096 / 2104
页数:9
相关论文
共 31 条
[1]   Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials [J].
Aaronson, NK ;
VisserPol, E ;
Leenhouts, GHMW ;
Muller, MJ ;
vanderSchot, ACM ;
vanDam, FSAM ;
Keus, RB ;
Koning, CCE ;
Huinink, WWT ;
vanDongen, JA ;
Dubbelman, R .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :984-996
[2]   Strategic physician communication and oncology clinical trials [J].
Albrecht, TL ;
Blanchard, C ;
Ruckdeschel, JC ;
Coovert, M ;
Strongbow, R .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3324-3332
[3]  
[Anonymous], 1989, CONTROL CLIN TRIALS, V10, P83
[4]  
[Anonymous], 1964, DECLARATION HELSINKI
[5]  
BOCHNER S, 1983, DOCTER PATIENT COMMU
[6]   INFORMED CONSENT - WHY ARE ITS GOALS IMPERFECTLY REALIZED [J].
CASSILETH, BR ;
ZUPKIS, RV ;
SUTTONSMITH, K ;
MARCH, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (16) :896-900
[7]   Informed consent for clinical trials: In search of the "best" method [J].
Edwards, SJL ;
Lilford, RJ ;
Thornton, J ;
Hewison, J .
SOCIAL SCIENCE & MEDICINE, 1998, 47 (11) :1825-1840
[8]   Effective communication skills are the key to good cancer care [J].
Fallowfield, L ;
Jenkins, V .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (11) :1592-1597
[9]  
GANZ PA, 1990, CANCER, V65, P2394, DOI 10.1002/1097-0142(19900515)65:10+<2394::AID-CNCR2820651509>3.0.CO
[10]  
2-#